Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults

NCT05422365 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Primary Immune Thrombocytopenia

Interventions

DRUG: Intravenous immunoglobulin (IVIG), 10% solution for infusion

Sponsor

Biopharma Plasma LLC